← Back to patent-cliff list
CAS 150196-34-2
3-(2-nitro-1H-imidazol-1-yl)-2-((tetrahydro-2H-pyran-2-yl)oxy)propyl 4-methylbenzenesulfonate
Codes: [18F]FMISO-001
Application context (from source-drug indications)
Squamous cell carcinoma18F-Fluoromisonidazole口咽肿瘤18F-FluoromisonidazoleGlioblastoma18F-FluoromisonidazoleBrain metastases18F-FluoromisonidazoleHead and neck squamous cell carcinoma18F-FluoromisonidazoleBreast cancer18F-Fluoromisonidazole
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 18F-Fluoromisonidazole | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
3-(2-nitro-1H-imidazol-1-yl)-2-((tetrahydro-2H-pyran-2-yl)oxy)propyl 4-methylbenzenesulfonate→[18F]FMISO-002→18F-Fluoromisonidazole
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.